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Relationship of primary immune 
thrombocytopenic purpura 
and atopia among children: a case 
control study
Gholamreza Bahoush1*, Amirbahador poorasgari1 & Marzieh nojomi2
Atopic dermatitis (AD) is a chronic disease affecting 10–30% of children and 2–10% of adults 
worldwide. it is manifested by the pruritus eczema lesions on the skin. immune thrombocytopenic 
purpura (itp) is the most common cause of acute onset of thrombocytopenia in childhood. the aim of 
this study was association of primary immune thrombocytopenic purpura and atopia among children. 
This case control study was performed on patients with acute and chronic ITP who were confirmed 
by a hematologist. the control group was also selected from the siblings of the patients who were 
healthy and almost matched by age and sex with the patient group. Data were entered into a 
questionnaire under the SPSS-20 program, and demographic data were analyzed descriptively. In the 
present study, 120 patients were enrolled, 60 of whom were in the patient group and 60 in the control 
group. Mean age was 95 and 98 months for patients and control. This study showed a significant 
association of ITP with allergic rhinitis (P = 0.02), atopic dermatitis (P = 0.004), itching (P = 0.042), 
and dry skin (P = 0.015). However, no significant relationship was found between ITP and asthma 
(P-value = 0.18). This study does not reveal the causality between atopy and ITP but clearly shows the 
association between atopy and ITP disease, so the prevalence of atopy in ITP patients is higher than 
the normal population. According to the results of this study, it is necessary to investigate the cause of 
atopy and ITP and to find other immunological and possibly genetic commonalities.
Atopic dermatitis is the most common chronic inflammatory skin disease, affecting about 10–30% of children 
and 2–10% of adults, thus making it a major global health problem. Onset of atopic dermatitis is typically present 
in infancy, which is characterized by recurrent periods of rash, dryness, and  itch1. Symptoms occur in 45% of 
patients within the first 6 months of life, and face and neck are involved in more than 90% of them. Another 
point to note is that 60% of infants and children with this disease recover up to 12 years of age and rarely persist 
until  adulthood2,3.
Atopic dermatitis is a complex genetic disorder that is often associated with other atopic disorders, such as 
allergic conjunctivitis, asthma, allergic rhinitis, or food allergies. These genetic disorders are prominent in infants 
and young children as atopic dermatitis, in older children asthma and in adolescents as inhaled  allergies4–6. 
The term atopic refers to the genetic tendency for allergenic disorders with eosinophilia in all patients, and 
elevated serum IgE levels (between 70 and 80%) in most  patients7,8. The manifestations of the disease and the 
location of the lesions vary with age and can be manifested by skin, respiratory and food allergies and mucosal 
 involvement9,10. The main treatment for the disease is topical corticosteroids, which are prescribed based on the 
severity of the lesions with low, moderate or severe  potency11. Atopic disorders such as allergic conjunctivitis, 
asthma, allergic rhinitis can occur in other diseases such as Immune thrombocytopenic purpura (ITP). ITP is one 
of the most common causes of thrombocytopenia and is a syndrome that causes platelet  dysfunction12. Antiplate-
let antibodies secreted by autoreactive B lymphocytes destroy platelets in the reticuloendothelial system, espe-
cially the spleen by binding to platelet antigens, which is described as the major immunological defect in  ITP13.
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The peak of the disease is between 1 and 2 years. Although it is limited in age from infancy to adulthood, 
boys and girls are treated equally in childhood. ITP is clinically common with petechia, purpura, and mucosal 
bleeding that usually results from an upper respiratory tract  infection14. It manifests itself in the majority of 
affected children with acute self-limitation up to 12 months, with or without treatment, and eventually the platelet 
count returns to  normal15,16. There are several risk factors for chronicity of the disease, one of which is initial 
lymphocyte  count17. Other studies have provided evidence of a chronic humoral deficiency in chronic  cases18. 
A growing body of evidence indicates that there is a link between autoimmune diseases and allergic diseases. 
However, few studies have evaluated the association between allergic diseases and ITP. In a study of children 
with AD, the incidence of ITP was higher in people with AD than in non-AD patients. It is also more likely to 
develop ITP in people with AD within the first 3 years after diagnosis of AD. Other autoimmune disorders in 
individuals with ITP and AD are more likely than those with ITP who do not have  AD19. Another study also 
shows that ITP increases the risk of allergic diseases such as AD in  children20.
Given the immunological abnormalities in the pathophysiology of both diseases, the association of both 
diseases with allergic diseases, and the presence of genetic risk factors in both diseases, we aimed to investigate 
the relationship between these two disorders in terms of epidemiology and clinical manifestations of atopy.
Methods
Study design. This case control study was performed on patients with acute and chronic ITP (treated or 
untreated patients) at Hospital, who were confirmed by a hematologist to rule out other causes. In order to rule 
out of Wiscott–Aldrich syndrome, only patients who had higher mean platelet volume (MPV) than normal at 
the time of diagnosis were enrolled. In this study, age and sex distribution are evenly matched. The control group 
was even selected as possible from the siblings of the patients who were healthy and almost similar in age and 
sex to the patient group. Questionnaires were prepared for both types of atopy based on demographic, acute or 
chronic disease and standard criteria in both groups and then completed by a pediatric immunologist. The sam-
pling method was non-probable and based on a questionnaire. Considering the prevalence of 5–20% of atopy 
in the literature, the sample size for each of the two case and control groups was estimated at 60 (power = 80%, 
alpha = 0.05) to make a difference of at least 20% between the two groups.
Data analysis. Data were entered into a questionnaire under the SPSS-20 program, demographic data 
were analyzed descriptively and statistical comparison between the two groups was done by Chi-square test. 
P-value < 0.05 was defined as significant.
ethical statement. All participants provided written informed consent. The study was conducted in 
accord-ance with the Declaration of Helsinki.All procedures were approved by the Human Research Committee 
of Iran University of Medical Sciences.
Results
A total of 120 patients were enrolled in this study, 60 in the patient group and 60 in the control group. Mean age 
of patients in patients and control groups was 95 and 98 months. The study subjects consisted of 32 boys and 
28 girls (Table 1).
Regarding the association between asthma and ITP in the patient and control groups, the results showed that, 
only 4 cases (6.3%) had asthma in the patient group and 56 cases (93.7%) did not have asthma. Furthermore, 59 
(98.3%) showed asthma in the control group and only 1 (1.7%) had asthma. Statistically, it can be concluded that 
there is no relationship between asthma and ITP (P = 0.18). The relationship between allergic conjunctivitis and 
ITP was indicated in Table 2 and the results showed that the frequency of allergic conjunctivitis among patients 
with ITP was ten times higher than that of the control group. Conjunctival disorders in patients with ITP is more 
likely than control group (P = 0.05) (Table 2).
The results showed that 14 patients (23.3%) were affected and 46 cases (76.7%) did not affected by atopic 
dermatitis. In addition, in the control group, 57 cases (95%) had no atopic dermatitis and only 3 cases (5%) 
developed atopic dermatitis. Results show that atopic dermatitis is more common in the ITP group as compared 
to control group (P = 0.004).
The association between ITP and the itch is shown in Table 3, indicating a low incidence of itching in infants 
with ITP. The absence of even one case in the control group indicates that the difference was statistically sig-
nificant among both group (P = 0.04), indicating that infants with ITP exhibited more pruritus than controls 
(Table 3).




Frequency Percent Frequency Percent
Yes 23 38.30 12 20
No 37 61.70 48 80
Total 60 100 60 100
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In the patient group, 10 cases (16.7%) had dry skin and the other 50 neonates (83.3%) were not affected. In 
the control group, 58 (96.7%) had no dry skin and only 2 (3.3%) experienced the complication. Therefore, there 
was a significant relationship between the prevalence of skin dryness in infants and ITP (P = 0.015), indicating 
that dry skin in infants with ITP was more common than the control group.
In addition, Atopic dermatitis, infant dry skin and pruritus were more frequent among acute ITP enrolled 
patients versus control group; these differences were statistically significant. On the other hand, This statistically 
significant difference was found only for orbital darkening among chronic ITP enrolled patients versus control 
group (Table 4).




Frequency Percent Frequency Percent
Yes 6 10 1 1.70
No 54 90 59 98.30
Total 60 100 60 100




Frequency Percent Frequency Percent
Yes 4 6.70 0 0
No 56 93.3 60 100
Total 60 100 60 100





Acute ITP 11 (36.7%) 19 (63.3%) 0.104
Chronic ITP 12 (40%) 18 (60%) 0.058
Control 13 (21.7%) 47 (78.3%)
Infant dry skin
Acute ITP 8 (26.7%) 22 (73.3%) 0.002
Chronic ITP 2 (6.7%) 28 (93.3%) 0.407
Control 2 (3.3%) 58 (96.7%)
Infant eczema
Acute ITP 5 (16.7%) 25 (83.3%) 0.078
Chronic ITP 4 (13.3%) 26 (86.7%) 0.164
Control 3 (5%) 57 (95%)
Atopic dermatitis
Acute ITP 9 (30%) 21 (70%) 0.005
Chronic ITP 5 (16.7%) 25 (83.3%) 0.133
Control 4 (6.7%) 56 (93.3%)
Infant pruritis
Acute ITP 3 (10%) 27 (90%) 0.035
Chronic ITP 1 (3.3%) 29 (96.7%) 0.333
Control 0 (0%) 60 (100%)
Orbital darkening
Acute ITP 2 (6.7%) 28 (93.3%) 0.257
Chronic ITP 4 (13.3%) 26 (86.7%) 0.041
Control 1 (1.7%) 59 (93.3%)
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Discussion
As expected, there was a strong significant association between ITP as an autoimmune disorder and atopic 
dermatitis as an immunological disorder. The results of our study, despite the low number of cases compared to 
other studies, show a strong significant relationship between these two immunological disorders. The severity 
of this relationship varies according to the type of atopic manifestation and the highest rate was associated with 
atopic dermatitis and the lowest was related to allergic conjunctivitis.
However, no significant relationship was found between ITP and asthma (P-value = 0.18), which was consist-
ent with the findings of Chiang et al. (2015), in which 1,203 children with ITP younger than 18 y of age were 
included between 1998 and 2008, as well as 4,812 individuals as control group.
The aforementioned study showed that the history of allergic diseases was much more common in children 
with ITP than in the control group. This comparison was performed for various allergic diseases such as aller-
gic rhinitis (17.2 vs. 8.96%), asthma (8.65 vs. 5.24%), allergic conjunctivitis (8.98 vs. 5.36%), urticaria (4.16 vs. 
2.41%), and atopic dermatitis (6.98 vs. 3.66%)13.
A cohort analysis study by Wei et al., in 2016, to investigate children with AD in comparison with non-AD 
controls revealed that from 2000 to 2007, 120,704 children with newly diagnosed AD and 241,408 children 
as non-AD controls were investigated for the risk of ITP.Finally, they showed that the incidence of ITP in AD 
patients was 1.72 times higher than in the control group, which was 2.4 times higher in children older than 2 years 
and gradually decreased with increasing  age21. These findings were consistent with our findings.
Paola Giordano et al., in a cohort retrospective analytic study on a large number of children with chronic ITP 
for the prevalence of positivity of antithyroid antibodies demonstrated that the significantly higher prevalence of 
positivity of antithyroid antibodies (antiTPO and anti-TG) in pediatric patients with chronic ITP in comparison 
with the pediatric  population22.
In another case–control study by Giordano et al. Of three patients with relapsed ITP after splenectomy was 
confirmed in vitro hyperactive B cells and high numbers of antibody-producing cells after  splenectomy23.
Surprisingly and may be contrary to expectation, in our study, we found a more significant correlation 
between acute ITP and Ethiopia versus chronic ITP. It may change in a study with a larger sample.
conclusion
The findings revealed a significant relationship between types of atopy (except for asthma) and ITP. This is 
one of the few studies on the relationship between atopy and ITP that can be very important in future studies. 
Other benefits of this study include the study of a atopic type such as atopic dermatitis, allergic rhinitis, allergic 
conjunctivitis, pruritus and neonatal dry skin, which is very comprehensive. The findings suggest a study of the 
types of possible genetic disorders and immune systems involved in the two diseases, which are identical, and 
that the results of these studies may pave the way for new therapies.
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